Last Updated: 07/07/2025
Design and development of ellagic acid derivatives for oral use in treatment of malaria
Objectives
This project aims to develop a (natural of hemisynthetic) derivative of ellagic acid which could be used orally.
Rationale and Abstract
Malaria is responsible for 600,000 deaths each year. Ellagic acid, a natural compound present in pomegranate, is highly active intraperitoneally against malaria (more active than quinine).
External reference
Date
Nov 2016
Funding Details
Belgian Federal Science Policy Office (BELSPO), Belgium
Grant ID: 26_8103
Project Site
Related Resources
